Singapore markets closed

Galapagos NV (GLPG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
31.98-0.97 (-2.95%)
As of 12:34PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close32.95
Open32.15
Bid31.89 x 100
Ask32.07 x 200
Day's range31.88 - 32.18
52-week range31.86 - 45.21
Volume120,874
Avg. volume120,380
Market cap2.107B
Beta (5Y monthly)0.03
PE ratio (TTM)N/A
EPS (TTM)-2.54
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est43.55
  • GlobeNewswire

    Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board

    Mechelen, Belgium; 26 March 2024, 21:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that during its meeting of 26 March 2024, the Board of Directors appointed Mr. Dickinson as Non-Executive Non-Independent Director by way of cooptation. Andrew Dickinson is Gilead's Chief Financial Officer (CFO) and replaces Daniel O’Day, Gilead’s Chairman and Chief Executive Officer (CEO), who was a member of the Galapagos Board of Directors from 22 October 2019 to 26 March 2024. Mr. Dickinson jo

  • Zacks

    Down -14.35% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround

    Galapagos NV (GLPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

  • Insider Monkey

    11 Oversold Biotech Stocks To Buy Right Now

    In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]